BridgeBio to Participate in November Investor Conferences

Rhea-AI Summary

BridgeBio (Nasdaq: BBIO) said members of its management team will present at two investor conferences in November 2025: a fireside chat at the UBS Global Healthcare Conference in Palm Beach Gardens, FL on Monday, November 10 at 1:15 pm ET, and a fireside chat at the Jefferies Global Healthcare Conference in London on Tuesday, November 18 at 11:00 am ET.

The company said live webcasts will be available on its Investors > Events and Presentations page and replay recordings will remain on the BridgeBio website for 90 days after each event.

News Market Reaction

-0.98%

1 alert

-0.98% News Effect

On the day this news was published, BBIO declined 0.98%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PALO ALTO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will host fireside chats at the following healthcare investor conferences:

• UBS Global Healthcare Conference, Palm Beach Gardens, FL: Fireside Chat on Monday, November 10 at 1:15 pm EST
• Jefferies Global Healthcare Conference, London, UK: Fireside Chat on Tuesday, November 18 at 11:00 am EST

To access the live webcast of BridgeBio’s presentations, please visit the “Events and Presentations” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.

About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio; Nasdaq: BBIO) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, and YouTube.

BridgeBio Media Contact:
Bubba Murarka, Executive Vice President, Corporate Development
contact@bridgebio.com  
(650)-789-8220

BridgeBio Investor Contact:
Chinmay Shukla, Senior Vice President, Strategic Finance
ir@bridgebio.com

FAQ

When will BridgeBio (BBIO) present at the UBS Global Healthcare Conference in November 2025?

BridgeBio will host a fireside chat at the UBS Global Healthcare Conference on Monday, November 10, 2025 at 1:15 pm ET.

What time is BridgeBio's (BBIO) Jefferies Global Healthcare Conference fireside chat in November 2025?

The Jefferies fireside chat is scheduled for Tuesday, November 18, 2025 at 11:00 am ET.

How can investors watch BridgeBio (BBIO) live webcasts for the November 2025 conferences?

Live webcasts will be available on BridgeBio's Investors > Events and Presentations page at https://investor.bridgebio.com.

Will BridgeBio (BBIO) provide replays of the November 2025 conference presentations?

Yes. Replays of the webcasts will be posted on the BridgeBio website and available for 90 days after each event.

Which BridgeBio (BBIO) executives will appear at the November 2025 conference fireside chats?

The announcement states that members of BridgeBio's management team will host the fireside chats; specific names were not provided.